Loading...
Semaglutide
India Pharmaceutical Trade Intelligence
Who Supplies Semaglutide to India from CANADA
India's semaglutide imports from CANADA total $387.7K across 59 shipments from 12 foreign suppliers. M/S GLOBYZ PHARMA leads with $137.1K in import value; the top 5 suppliers together control 91.1% of this origin. Leading Indian buyers include CHEMO INDIA FORMULATION PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for semaglutide — a diversified sourcing base with multiple active suppliers from CANADA.
Top foreign suppliers (CANADA) — Ranked by import value
M/S GLOBYZ PHARMA is the leading Semaglutide supplier from CANADA to India, with import value of $137.1K across 3 shipments. The top 5 suppliers — M/S GLOBYZ PHARMA, ADIRA MEDICA INC, ADIRAMEDICA INC, GLOBYZ PHARMA, APOTEX INC. — collectively account for 91.1% of total import value from this origin.
Top foreign suppliers (CANADA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M/S GLOBYZ PHARMA | $137.1K | 3 | 35.4% |
| 2 | ADIRA MEDICA INC | $93.0K | 11 | 24.0% |
| 3 | ADIRAMEDICA INC | $70.8K | 13 | 18.3% |
| 4 | GLOBYZ PHARMA | $41.0K | 14 | 10.6% |
| 5 | APOTEX INC. | $11.2K | 2 | 2.9% |
| 6 | ADIRA MEDICA INC. | $9.5K | 2 | 2.4% |
| 7 | RX SOURCE CORP. | $8.4K | 3 | 2.2% |
| 8 | M/S TARO PHARMACEUTICALS INC | $6.7K | 3 | 1.7% |
| 9 | ADIRAMEDICA INC. | $3.1K | 2 | 0.8% |
| 10 | NEW LIFE MEDICALS (USA) INC. | $2.7K | 1 | 0.7% |
| 11 | APOTEX INC | $2.7K | 4 | 0.7% |
| 12 | NEW LIFE MEDICALS (USA) INC | $1.4K | 1 | 0.4% |
Showing top 12 of 12 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CANADA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CHEMO INDIA FORMULATION PRIVATE LIMITED | $137.1K | 3 | 35.4% |
| 2 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI | $105.4K | 14 | 27.2% |
| 3 | DR.REDDY'S LABORATORIES LTD | $69.6K | 14 | 18.0% |
| 4 | ZYDUS LIFESCIENCES LIMITED | $37.3K | 9 | 9.6% |
| 5 | RAPTIM RESEARCH PRIVATE LIMITED | $11.2K | 2 | 2.9% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $6.7K | 3 | 1.7% |
| 7 | CITUS RESEARCH LLP | $5.8K | 1 | 1.5% |
| 8 | DR.REDDY'S LABORATORIES LIMITED | $4.4K | 1 | 1.1% |
| 9 | DR REDDY S LABORATORIES LIMITED | $4.4K | 1 | 1.1% |
| 10 | LUPIN LIMITED | $3.1K | 7 | 0.8% |
| 11 | APOTEX RESEARCH PRIVATE LIMITED | $2.7K | 4 | 0.7% |
Import Statistics
- Import Value
- $387.7K
- Shipments
- 59
- Foreign Suppliers
- 12
- Indian Buyers
- 11
- Avg. Shipment
- $6.6K
Other Semaglutide Import Origins
Related Analysis
Frequently Asked Questions — Semaglutide Imports from CANADA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Semaglutide suppliers from CANADA to India?
The top Semaglutide suppliers from CANADA to India include M/S GLOBYZ PHARMA, ADIRA MEDICA INC, ADIRAMEDICA INC. The leading supplier is M/S GLOBYZ PHARMA with import value of $137.1K USD across 3 shipments. India imported Semaglutide worth $387.7K USD from CANADA in total across 59 shipments.
QHow much Semaglutide does India import from CANADA?
India imported Semaglutide worth $387.7K USD from CANADA across 59 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Semaglutide from CANADA?
The main Indian buyers of Semaglutide sourced from CANADA include CHEMO INDIA FORMULATION PRIVATE LIMITED, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, DR.REDDY'S LABORATORIES LTD. The largest buyer is CHEMO INDIA FORMULATION PRIVATE LIMITED with $137.1K in imports across 3 shipments.
QWhat is the total value of Semaglutide imports from CANADA to India?
The total value of Semaglutide imports from CANADA to India is $387.7K USD, across 59 shipments and 12 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CANADA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Semaglutide.
- 2.Supplier/Buyer Matching: 12 foreign suppliers from CANADA and 11 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $387.7K aggregated from 59 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
59 Verified Shipments
12 suppliers, 11 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists